Hepcidin and its potential clinical utility

Cell Biology International

Volumn 39, Issue 11, 2015, Pages 1191-1202

  Miseta, Attila ^a   Nagy, Judit ^a   Nagy, Tamas ^a   Poór, Viktor Soma ^a   Fekete, Zsuzsanna ^a   Sipos, Katalin ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Diagnostics; Hepcidin; Iron homeostasis; Liver; Prohepcidin

Indexed keywords

BONE MORPHOGENETIC PROTEIN 6; CERULOPLASMIN; FERRITIN; FERROCHELATASE; FERROPORTIN 1; FRATAXIN; HEME OXYGENASE 1; HEMOJUVELIN; HEPCIDIN; INTERLEUKIN 6; IRON; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; PROHEPCIDIN; PROTON COUPLED FOLATE TRANSPORTER; TRANSFERRIN; TRANSFERRIN RECEPTOR; TRANSFERRIN RECEPTOR 2; BIOLOGICAL MARKER;

ANEMIA; CENTRAL NERVOUS SYSTEM DISEASE; COLORECTAL CANCER; CROHN DISEASE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMOCHROMATOSIS; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE SYNTHESIS; HORMONE URINE LEVEL; HUMAN; INFLAMMATION; INSULIN RESISTANCE; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON METABOLISM; IRON OVERLOAD; IRON THERAPY; IRON TRANSPORT; LIVER CIRRHOSIS; MALIGNANT NEOPLASTIC DISEASE; MASS SPECTROMETRY; METABOLIC REGULATION; METABOLIC SYNDROME X; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; NONHUMAN; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; REVIEW; RHEUMATOID ARTHRITIS; ANIMAL; BLOOD; HOMEOSTASIS; IRON METABOLISM DISORDERS; METABOLISM;

ANIMALS; BIOMARKERS; HEPCIDINS; HOMEOSTASIS; HUMANS; IRON; IRON METABOLISM DISORDERS;

EID: 84944512035     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10505     Document Type: Review

References (124)

1. Abd Elmonem E, Tharwa el S, Farag MA, Fawzy A, El Shinnawy SF, Suliman S ( 2009) Hepcidin mRNA level as a parameter of disease progression in chronic hepatitis C and hepatocellular carcinoma. J Egypt Natl Canc Inst 21:333-42.
2. Andriopoulos B, Jr., Corradini E, Xia Y, Faasse SA, Chen S, Grgurevic L, Knutson MD, Pietrangelo A, Vukicevic S, Lin HY, Babitt JL ( 2009) BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet 41:482-7.
3. Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, Taube DH, Bloom SR, Tam FW, Chapman RS, Maxwell PH, Choi P ( 2009) Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int 75:976-81.
4. Bacchetta J, Zaritsky JJ, Sea JL, Chun RF, Lisse TS, Zavala K, Nayak A, Wesseling-Perry K, Westerman M, Hollis BW, Salusky IB, Hewison M ( 2014) Suppression of iron-regulatory hepcidin by vitamin D. J Am Soc Nephrol 25:564-72.
5. Basseri RJ, Nemeth E, Vassilaki ME, Basseri B, Enayati P, Shaye O, Bourikas LA, Ganz T, Papadakis KA ( 2013) Hepcidin is a key mediator of anemia of inflammation in Crohn's disease. J Crohns Colitis 7:e286-91.
6. Beaumont C ( 2010) Multiple regulatory mechanisms act in concert to control ferroportin expression and heme iron recycling by macrophages. Haematologica 95:1233-6.
7. Brancatisano FL, Maisetta G, Di Luca M, Esin S, Bottai D, Bizzarri R, Campa M, Batoni G ( 2014) Inhibitory effect of the human liver-derived antimicrobial peptide hepcidin 20 on biofilms of polysaccharide intercellular adhesin (PIA)-positive and PIA-negative strains of Staphylococcus epidermidis. Biofouling 30:435-46.
8. Bregman DB, Morris D, Koch TA, He A, Goodnough LT ( 2013) Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia. Am J Hematol 88:97-101.
9. Burte F, Brown BJ, Orimadegun AE, Ajetunmobi WA, Afolabi NK, Akinkunmi F, Kowobari O, Omokhodion S, Osinusi K, Akinbami FO, Shokunbi WA, Sodeinde O, Fernandez-Reyes D ( 2013) Circulatory hepcidin is associated with the anti-inflammatory response but not with iron or anemic status in childhood malaria. Blood 121:3016-22.
10. Camaschella C ( 2013) Iron and hepcidin: a story of recycling and balance. Hematology Am Soc Hematol Educ Program 2013:1-8.
11. Campostrini N, Castagna A, Zaninotto F, Bedogna V, Tessitore N, Poli A, Martinelli N, Lupo A, Olivieri O, Girelli D ( 2010) Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS. J Biomed Biotechnol 2010:329646.
12. Casanovas G, Banerji A, d'Alessio F, Muckenthaler MU, Legewie S ( 2014) A multi-scale model of hepcidin promoter regulation reveals factors controlling systemic iron homeostasis. PLoS Comput Biol 10:e1003421.
13. Chua AC, Klopcic B, Lawrance IC, Olynyk JK, Trinder D ( 2010) Iron: an emerging factor in colorectal carcinogenesis. World J Gastroenterol 16:663-72.
14. Cook JD ( 1999) Defining optimal body iron. Proc Nutr Soc 58:489-95.
15. Cooke KS, Hinkle B, Salimi-Moosavi H, Foltz I, King C, Rathanaswami P, Winters A, Steavenson S, Begley CG, Molineux G, Sasu BJ ( 2013) A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates. Blood 122:3054-61.
16. Crichton RR, Dexter DT, Ward RJ ( 2011) Brain iron metabolism and its perturbation in neurological diseases. J Neural Transm 118:301-14.
17. Datz C, Felder TK, Niederseer D, Aigner E ( 2013) Iron homeostasis in the metabolic syndrome. Eur J Clin Invest 43:215-24.
18. De Domenico I, Lo E, Yang B, Korolnek T, Hamza I, Ward DM, Kaplan J ( 2011a) The role of ubiquitination in hepcidin-independent and hepcidin-dependent degradation of ferroportin. Cell Metab 14:635-46.
19. De Domenico I, Ward DM, Kaplan J ( 2011b) Hepcidin and ferroportin: the new players in iron metabolism. Semin Liver Dis 31:272-9.
20. Del Gaudio G, Lombardi L, Maisetta G, Esin S, Batoni G, Sanguinetti M, Senesi S, Tavanti A ( 2013) Antifungal activity of the non cytotoxic human peptide hepcidin 20 against fluconazole resistant Candida glabrata in human vaginal fluid. Antimicrob Agents Chemother 57:4314-21.
21. del Giudice EM, Santoro N, Amato A, Brienza C, Calabro P, Wiegerinck ET, Cirillo G, Tartaglione N, Grandone A, Swinkels DW, Perrone L ( 2009) Hepcidin in obese children as a potential mediator of the association between obesity and iron deficiency. J Clin Endocrinol Metab 94:5102-7.
22. Du F, Qian ZM, Luo Q, Yung WH, Ke Y ( 2014) Hepcidin suppresses brain iron accumulation by downregulating iron transport proteins in iron-overloaded rats. Mol Neurobiol 50. epub in press doi: 10.1007/s12035-014-8847-x
23. Finberg KE ( 2013) Regulation of systemic iron homeostasis. Curr Opin Hematol 20:208-14.
24. Gaffney-Stomberg E, McClung JP ( 2012) Inflammation and diminished iron status: mechanisms and functional outcomes. Curr Opin Clin Nutr Metab Care 15:605-13.
25. Gammella E, Diaz V, Recalcati S, Buratti P, Samaja M, Dey S, Noguchi CT, Gassmann M, Cairo G ( 2015) Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly. Am J Physiol Regul Integr Comp Physiol 308:R330-5.
26. Ganz T ( 2005) Cellular iron: ferroportin is the only way out. Cell Metab 1:155-7.
27. Ganz T ( 2011) Hepcidin and iron regulation, 10 years later. Blood 117:4425-33.
28. Ganz T ( 2013) Systemic iron homeostasis. Physiol Rev 93:1721-41.
29. Ganz T, Nemeth E ( 2012) Hepcidin and iron homeostasis. Biochim Biophys Acta 1823:1434-43.
30. Gao G, Chang YZ ( 2014) Mitochondrial ferritin in the regulation of brain iron homeostasis and neurodegenerative diseases. Front Pharmacol 5:19.
31. Garrick MD, Garrick LM ( 2009) Cellular iron transport. Biochim Biophys Acta 1790:309-25.
32. Gkouvatsos K, Papanikolaou G, Pantopoulos K ( 2012) Regulation of iron transport and the role of transferrin. Biochim Biophys Acta 1820:188-202.
33. Goyal J, McCleskey B, Adamski J ( 2013) Peering into the future: hepcidin testing. Am J Hematol 88:976-8.
34. Guida C, Altamura S, Klein FA, Galy B, Boutros M, Ulmer AJ, Hentze MW, Muckenthaler MU ( 2015) A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia. Blood 125:2265-75.
35. Hao J, Li YW, Xie MQ, Li AX ( 2012) Molecular cloning, recombinant expression and antibacterial activity analysis of hepcidin from Simensis crocodile (Crocodylus siamensis). Comp Biochem Physiol B Biochem Mol Biol 163:309-15.
36. Hare D, Ayton S, Bush A, Lei P ( 2013) A delicate balance: iron metabolism and diseases of the brain. Front Aging Neurosci 5:34.
37. Hentze MW, Muckenthaler MU, Galy B, Camaschella C ( 2010) Two to tango: regulation of Mammalian iron metabolism. Cell 142:24-38.
38. Hocquellet A, le Senechal C, Garbay B ( 2012) Importance of the disulfide bridges in the antibacterial activity of human hepcidin. Peptides 36:303-7.
39. Huang FW, Pinkus JL, Pinkus GS, Fleming MD, Andrews NC ( 2005) A mouse model of juvenile hemochromatosis. J Clin Invest 115:2187-91.
40. Huang ML, Austin CJ, Sari MA, Rahmanto YS, Ponka P, Vyoral D, Richardson DR ( 2013) Hepcidin bound to alpha2-macroglobulin reduces ferroportin-1 expression and enhances its activity at reducing serum iron levels. J Biol Chem 288:25450-65.
41. Hunter HN, Fulton DB, Ganz T, Vogel HJ ( 2002) The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem 277:37597-603.
42. Jomova K, Valko M ( 2011) Importance of iron chelation in free radical-induced oxidative stress and human disease. Curr Pharm Des 17:3460-73.
43. Jordan JB, Poppe L, Haniu M, Arvedson T, Syed R, Li V, Kohno H, Kim H, Schnier PD, Harvey TS, Miranda LP, Cheetham J, Sasu BJ ( 2009) Hepcidin revisited, disulfide connectivity, dynamics, and structure. J Biol Chem 284:24155-67.
44. Kartikasari AE, Roelofs R, Schaeps RM, Kemna EH, Peters WH, Swinkels DW, Tjalsma H ( 2008) Secretion of bioactive hepcidin-25 by liver cells correlates with its gene transcription and points towards synergism between iron and inflammation signaling pathways. Biochim Biophys Acta 1784:2029-37.
45. Kato A ( 2010) Increased hepcidin-25 and erythropoietin responsiveness in patients with cardio-renal anemia syndrome. Future Cardiol 6:769-71.
46. Kautz L, Nemeth E ( 2014) Molecular liaisons between erythropoiesis and iron metabolism. Blood 124:479-82.
47. Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D ( 2005) Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106:1864-6.
48. Kemna EH, Tjalsma H, Podust VN, Swinkels DW ( 2007) Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem 53:620-8.
49. Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM ( 2009) Ferritin for the clinician. Blood Rev 23:95-104.
50. Koulaouzidis A, Said E, Cottier R, Saeed AA ( 2009) Soluble transferrin receptors and iron deficiency, a step beyond ferritin. A systematic review. J Gastrointestin Liver Dis 18:345-52.
51. Kroot JJ, Hendriks JC, Laarakkers CM, Klaver SM, Kemna EH, Tjalsma H, Swinkels DW ( 2009) (Pre) analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies. Anal Biochem 389:124-9.
52. Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW ( 2011) Hepcidin in human iron disorders: diagnostic implications. Clin Chem 57:1650-69.
53. Kroot JJ, van Herwaarden AE, Tjalsma H, Jansen RT, Hendriks JC, Swinkels DW ( 2012) Second round robin for plasma hepcidin methods: first steps toward harmonization. Am J Hematol 87:977-83.
54. Kuragano T, Furuta M, Shimonaka Y, Kida A, Yahiro M, Otaki Y, Hasuike Y, Matsumoto A, Nakanishi T ( 2013) The removal of serum hepcidin by different dialysis membranes. Int J Artif Organs 36:633-9.
55. Laarakkers CM, Wiegerinck ET, Klaver S, Kolodziejczyk M, Gille H, Hohlbaum AM, Tjalsma H, Swinkels DW ( 2013) Improved mass spectrometry assay for plasma hepcidin: detection and characterization of a novel hepcidin isoform. PLoS ONE 8:e75518.
56. Lamy PJ, Durigova A, Jacot W ( 2014) Iron homeostasis and anemia markers in early breast cancer. Clin Chim Acta 434:34-40.
57. Lesbordes-Brion JC, Viatte L, Bennoun M, Lou DQ, Ramey G, Houbron C, Hamard G, Kahn A, Vaulont S ( 2006) Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood 108:1402-5.
58. Lin D, Ding J, Liu JY, He YF, Dai Z, Chen CZ, Cheng WZ, Zhou J, Wang X ( 2013) Decreased serum hepcidin concentration correlates with brain iron deposition in patients with HBV-related cirrhosis. PLoS ONE 8:e65551.
59. Liu Q, Davidoff O, Niss K, Haase VH ( 2012) Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis. J Clin Invest 122:4635-44.
60. Maccio A, Madeddu C, Gramignano G, Mulas C, Tanca L, Cherchi MC, Floris C, Omoto I, Barracca A, Ganz T ( 2015) The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study. Haematologica 100:124-32.
61. Macdougall IC, Malyszko J, Hider RC, Bansal SS ( 2010) Current status of the measurement of blood hepcidin levels in chronic kidney disease. Clin J Am Soc Nephrol 5:1681-9.
62. Maruna P, Lindner J, Kunstyr J, Plocova K, Hubacek J ( 2009) Plasma prohepcidin as a negative acute phase reactant after large cardiac surgery with a deep hypothermic circulatory arrest. Physiol Res 58:827-33.
63. Massoura AN, Dover TJ, Newman AS, Barnes NM ( 2011) The identification of N-glycosylated residues of the human 5-HT3B receptor subunit: importance for cell membrane expression. J Neurochem 116:975-83.
64. McCarthy RC, Kosman DJ ( 2014) Glial cell ceruloplasmin and hepcidin differentially regulate iron efflux from brain microvascular endothelial cells. PLoS ONE 9:e89003.
65. Mei S, Wang H, Fu R, Qu W, Xing L, Wang G, Song J, Liu H, Li L, Wang X, Wu Y, Guan J, Ruan E, Shao Z ( 2014) Hepcidin and GDF15 in anemia of multiple myeloma. Int J Hematol 100:266-73.
66. Mills E, Dong XP, Wang F, Xu H ( 2010) Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders. Future Med Chem 2:51-64.
67. Munoz M, Villar I, Garcia-Erce JA ( 2009) An update on iron physiology. World J Gastroenterol 15:4617-26.
68. Nagy J, Lakner L, Poor VS, Pandur E, Mozsik G, Miseta A, Sipos K ( 2010) Serum prohepcidin levels in chronic inflammatory bowel diseases. J Crohns Colitis 4:649-53.
69. Nakanishi T, Kuragano T, Kaibe S, Nagasawa Y, Hasuike Y ( 2012) Should we reconsider iron administration based on prevailing ferritin and hepcidin concentrations? Clin Exp Nephrol 16:819-26.
70. Nam H, Wang CY, Zhang L, Zhang W, Hojyo S, Fukada T, Knutson MD ( 2013) ZIP14 and DMT1 in the liver, pancreas, and heart are differentially regulated by iron deficiency and overload: implications for tissue iron uptake in iron-related disorders. Haematologica 98:1049-57.
71. Nemeth E, Preza GC, Jung CL, Kaplan J, Waring AJ, Ganz T ( 2006) The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood 107:328-33.
72. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T ( 2004) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113:1271-6.
73. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S ( 2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 98:8780-5.
74. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, Sirito M, Sawadogo M, Kahn A, Vaulont S ( 2002) Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 99:4596-601.
75. Oliveira-Filho JP, Badial PR, Cunha PH, Peiro JR, Araujo JP, Jr., Divers TJ, Winand NJ, Borges AS ( 2012) Lipopolysaccharide infusion up-regulates hepcidin mRNA expression in equine liver. Innate Immun 18:438-46.
76. Oustamanolakis P, Koutroubakis IE, Messaritakis I, Malliaraki N, Sfiridaki A, Kouroumalis EA ( 2011) Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease. Eur J Gastroenterol Hepatol 23:262-8.
77. Pandur E, Nagy J, Poor VS, Sarnyai A, Huszar A, Miseta A, Sipos K ( 2009) Alpha-1 antitrypsin binds preprohepcidin intracellularly and prohepcidin in the serum. FEBS J 276:2012-21.
78. Pandur E, Sipos K, Grama L, Nagy J, Poor VS, Setalo G, Miseta A, Fekete Z ( 2013) Prohepcidin binds to the HAMP promoter and autoregulates its own expression. Biochem J 451:301-11.
79. Pantopoulos K, Porwal SK, Tartakoff A, Devireddy L ( 2012) Mechanisms of mammalian iron homeostasis. Biochemistry 51:5705-24.
80. Papillard-Marechal S, Sznajder M, Hurtado-Nedelec M, Alibay Y, Martin-Schmitt C, Dehoux M, Westerman M, Beaumont C, Chevallier B, Puy H, Stheneur C ( 2012) Iron metabolism in patients with anorexia nervosa: elevated serum hepcidin concentrations in the absence of inflammation. Am J Clin Nutr 95:548-54.
81. Park CH, Valore EV, Waring AJ, Ganz T ( 2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276:7806-10.
82. Paul VD, Lill R ( 2014) SnapShot: eukaryotic Fe-S protein biogenesis. Cell Metab 20:384-e1.
83. Peslova G, Petrak J, Kuzelova K, Hrdy I, Halada P, Kuchel PW, Soe-Lin S, Ponka P, Sutak R, Becker E, Huang ML, Suryo Rahmanto Y, Richardson DR, Vyoral D. ( 2009) Hepcidin, the hormone of iron metabolism, is bound specifically to alpha-2-macroglobulin in blood. Blood 113:6225-36.
84. Peters HP, Laarakkers CM, Pickkers P, Masereeuw R, Boerman OC, Eek A, Cornelissen EA, Swinkels DW, Wetzels JF ( 2013) Tubular reabsorption and local production of urine hepcidin-25. BMC Nephrol 14:70.
85. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O ( 2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276:7811-9.
86. Pinto JP, Ribeiro S, Pontes H, Thowfeequ S, Tosh D, Carvalho F, Porto G ( 2008) Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha. Blood 111:5727-33.
87. Piperno A, Galimberti S, Mariani R, Pelucchi S, Ravasi G, Lombardi C, Bilo G, Revera M, Giuliano A, Faini A, Mainini V, Westerman M, Ganz T, Valsecchi MG, Mancia G, Parati G, investigators H ( 2011) Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project. Blood 117:2953-9.
88. Poli M, Luscieti S, Gandini V, Maccarinelli F, Finazzi D, Silvestri L, Roetto A, Arosio P ( 2010) Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation. Haematologica 95: 1832-40.
89. Qian Y, Zhang S, Guo W, Ma J, Chen Y, Wang L, Zhao M, Liu S. ( 2015). Polychlorinated biphenyls (PCBs) inhibit hepcidin expression through an estrogen-like effect associated with disordered systemic iron homeostasis. Chem Res Toxicol 28:629-40.
90. Raha AA, Vaishnav RA, Friedland RP, Bomford A, Raha-Chowdhury R ( 2013) The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease. Acta Neuropathol Commun 1:55.
91. Ramey G, Deschemin JC, Durel B, Canonne-Hergaux F, Nicolas G, Vaulont S ( 2010) Hepcidin targets ferroportin for degradation in hepatocytes. Haematologica 95:501-4.
92. Ravasi G, Pelucchi S, Greni F, Mariani R, Giuliano A, Parati G, Silvestri L, Piperno A ( 2014) Circulating factors are involved in hypoxia-induced hepcidin suppression. Blood Cells Mol Dis 53:204-10.
93. Richardson DR, Lane DJ, Becker EM, Huang ML, Whitnall M, Suryo Rahmanto Y, Sheftel AD, Ponka P ( 2010) Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc Natl Acad Sci USA 107:10775-82.
94. Roe MA, Collings R, Dainty JR, Swinkels DW, Fairweather-Tait SJ ( 2009) Plasma hepcidin concentrations significantly predict interindividual variation in iron absorption in healthy men. Am J Clin Nutr 89:1088-91.
95. Ruchala P, Nemeth E ( 2014) The pathophysiology and pharmacology of hepcidin. Trends Pharmacol Sci 35:155-61.
96. Ruivard M, Laine F, Ganz T, Olbina G, Westerman M, Nemeth E, Rambeau M, Mazur A, Gerbaud L, Tournilhac V, Abergel A, Philippe P, Deugnier Y, Coudray C ( 2009) Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidin. J Hepatol 50:1219-25.
97. Sharma S, Nemeth E, Chen YH, Goodnough J, Huston A, Roodman GD, Ganz T, Lichtenstein A ( 2008) Involvement of hepcidin in the anemia of multiple myeloma. Clin Cancer Res 14:3262-7.
98. Stehling O, Wilbrecht C, Lill R ( 2014) Mitochondrial iron-sulfur protein biogenesis and human disease. Biochimie 100:61-77.
99. Swellam M, Gabal KM, Youssef SS ( 2013) Interleukin-1 receptor antagonist gene polymorphism and hepcidin in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. IUBMB Life 65:883-8.
100. Tanno T, Rabel A, Alleyne M, Lee YT, Dahut WL, Gulley JL, Miller JL ( 2011) Hepcidin, anaemia, and prostate cancer. BJU Int 107:678-9.
101. Tao Y, Wang Y, Rogers JT, Wang F ( 2014a) Perturbed iron distribution in Alzheimer's disease serum, cerebrospinal fluid, and selected brain regions: a systematic review and meta-analysis. Cerebrospinal Fluid 679-90.
102. Tao Y, Zhao DM, Wen Y ( 2014b) Expression, purification and antibacterial activity of the channel catfish hepcidin mature peptide. Protein Expr Purif 94:73-8.
103. Theurl I, Theurl M, Seifert M, Mair S, Nairz M, Rumpold H, Zoller H, Bellmann-Weiler R, Niederegger H, Talasz H, Weiss G ( 2008) Autocrine formation of hepcidin induces iron retention in human monocytes. Blood 111:2392-9.
104. Tisi MC, Bozzoli V, Giachelia M, Massini G, Ricerca BM, Maiolo E, D'Alo F, Larocca LM, Piciocchi A, Tjalsma H, Swinkels DW, Voso MT, Leone G, Hohaus S ( 2014) Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. Leuk Lymphoma 55:270-5.
105. Tsochatzis E, Papatheodoridis GV, Koliaraki V, Hadziyannis E, Kafiri G, Manesis EK, Mamalaki A, Archimandritis AJ ( 2010) Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C. J Viral Hepat 17:800-6.
106. Tsuchiya K, Nitta K ( 2013) Hepcidin is a potential regulator of iron status in chronic kidney disease. Ther Apher Dial 17:1-8.
107. Urrutia P, Aguirre P, Esparza A, Tapia V, Mena NP, Arredondo M, Gonzalez-Billault C, Nunez MT ( 2013) Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J Neurochem 126:541-9.
108. Valore EV, Ganz T ( 2008) Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin. Blood Cells Mol Dis 40:132-8.
109. van Bokhoven MA, van Deursen CT, Swinkels DW ( 2011) Diagnosis and management of hereditary haemochromatosis. BMJ 342:c7251.
110. van der Weerd NC, Grooteman MP, Bots ML, van den Dorpel MA, den Hoedt CH, Mazairac AH, Nube MJ, Penne EL, Gaillard CA, Wetzels JF, Wiegerinck ET, Swinkels DW, Blankestijn PJ, Ter Wee, ( 2012) Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents. PLoS ONE 7:e39783.
111. van Eijk LT, Kroot JJ, Tromp M, van der Hoeven JG, Swinkels DW, Pickkers P ( 2011) Inflammation-induced hepcidin-25 is associated with the development of anemia in septic patients: an observational study. Crit Care 15:R9.
112. Vaubel RA, Isaya G ( 2013) Iron-sulfur cluster synthesis, iron homeostasis and oxidative stress in Friedreich ataxia. Mol Cell Neurosci 55:50-61.
113. Vermeulen E, Vermeersch P ( 2012) Hepcidin as a biomarker for the diagnosis of iron metabolism disorders: a review. Acta Clin Belg 67:190-7.
114. Wang CY, Meynard D, Lin HY ( 2014) The role of TMPRSS6/matriptase-2 in iron regulation and anemia. Front Pharmacol 5:114.
115. Wang Q, Du F, Qian ZM, Ge XH, Zhu L, Yung WH, Yang L, Ke Y ( 2008) Lipopolysaccharide induces a significant increase in expression of iron regulatory hormone hepcidin in the cortex and substantia nigra in rat brain. Endocrinology 149:3920-5.
116. Wang SM, Fu LJ, Duan XL, Crooks DR, Yu P, Qian ZM, Di XJ Li, Chang TA ( 2010) Role of hepcidin in murine brain iron metabolism. Cell Mol Life Sci 67:123-33.
117. Worthen CA, Enns CA ( 2014) The role of hepatic transferrin receptor 2 in the regulation of iron homeostasis in the body. Front Pharmacol 5:34.
118. Wu XG, Wang Y, Wu Q, Cheng WH, Liu W, Zhao Y, Mayeur C, Schmidt PJ, Yu PB, Wang F, Xia Y ( 2014) HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression. Blood 124:1335-43.
119. Zechel S, Huber-Wittmer K, von Bohlen und Halbach O ( 2006) Distribution of the iron-regulating protein hepcidin in the murine central nervous system. J Neurosci Res 84: 790-800.
120. Zhang AS, Enns CA ( 2009) Molecular mechanisms of normal iron homeostasis. Hematology 2009:207-14.
121. Zhang X, Rovin BH ( 2010) Hepcidin expression by human monocytes in response to adhesion and pro-inflammatory cytokines. Biochim Biophys Acta 1800:1262-7.
122. Zhang Z, Guo X, Herrera C, Tao Y, Wu Q, Wu A, Wang H, Bartnikas TB, Wang F ( 2014) Bmp6 expression can be regulated independently of liver iron in mice. PLoS ONE 9:e84906.
123. Zhao N, Zhang AS, Enns CA ( 2013) Iron regulation by hepcidin. J Clin Invest 123:2337-43.
124. Zipperer E, Post JG, Herkert M, Kundgen A, Fox F, Haas R, Gattermann N, Germing U ( 2013) Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome. Ann Hematol 92:1617-23.